
Dailyglim M 4mg/500mg Tablet SR
Marketer
Leeford Healthcare Ltd
Salt Composition
Glimepiride (4mg) + Metformin (500mg)
Overview Dailyglim M 4mg/500mg Tablet SR
Metformin/glimepiride extended-release tablets (4mg/500mg) are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate blood glucose, increasing the risk of complications like kidney damage, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.
Uses of Dailyglim M 4mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Dailyglim M 4mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dailyglim M 4mg/500mg Extended-Release tablets should be administered with meals.
Common Side effects of Dailyglim M 4mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Dailyglim M 4mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Dailyglim M 4mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
How Dailyglim M 4mg/500mg Tablet SR works:
Dailyglim M SR tablets (4mg/500mg) combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Dailyglim M 4mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dailyglim M 4mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged breastfeeding while taking Dailyglim M 4mg/500mg SR tablets is contraindicated due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Dailyglim M 4mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Dailyglim M 4mg/500mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Dailyglim M 4mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced starting dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Dailyglim M 4mg/500mg Tablet SR :
Should you forget a Dailyglim M 4mg/500mg SR tablet, take it immediately. But, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dailyglim M 4mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
